Cognition Therapeutics, Inc. (CGTX) Reports In-Line Q2 EPS

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q2 EPS of ($0.11), in-line with the analyst estimate of ($0.11).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Reading (RDI) Tops Q2 EPS by 4c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results